Evidence map›Paper›PMID 28149694›Full record

ArticlePeerJ2017

Exploration of immunoglobulin transcriptomes from mice immunized with three-finger toxins and phospholipases A

Andreas H Laustsen, Mikael Engmark, Christopher Clouser, Sonia Timberlake, Francois Vigneault, José María Gutiérrez, Bruno Lomonte

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Anti-Neurotoxins fromToxins · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in immunology · 2021
    Review
  14. Review
  15. Review
  16. Causes and Consequences of Snake Venom Variation.Trends in pharmacological sciences · 2020
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Andreas H LaustsenDepartment of Biotechnology and Biomedicine, Technical University of Denmark , Kgs. Lyngby , Denmark.
Mikael EngmarkDepartment of Biotechnology and Biomedicine, Technical University of Denmark, Kgs. Lyngby, Denmark; Department of Bio and Health Informatics, Technical University of Denmark, Kgs. Lyngby, Denmark.
Christopher ClouserJuno Therapeutics, Seattle, WA, United States of America; AbVitro, Boston, MA, United States of America.
Sonia TimberlakeFinch Therapeutics , Somerville , MA , United States of America.
Francois VigneaultJuno Therapeutics, Seattle, WA, United States of America; AbVitro, Boston, MA, United States of America.
José María GutiérrezInstituto Clodomiro Picado, Universidad de Costa Rica , San José , Costa Rica.
Bruno LomonteInstituto Clodomiro Picado, Universidad de Costa Rica , San José , Costa Rica.
Technical University of Denmark · DKUniversidad de Costa Rica · CRFinch Therapeutics (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Snakebite envenomings represent a neglected public health issue in many parts of the rural tropical world. Animal-derived antivenoms have existed for more than a hundred years and are effective in neutralizing snake venom toxins when timely administered. However, the low immunogenicity of many small but potent snake venom toxins represents a challenge for obtaining a balanced immune response against the medically relevant components of the venom. Here, we employ high-throughput sequencing of the immunoglobulin (Ig) transcriptome of mice immunized with a three-finger toxin and a phospholipase A

Indexed as

AntibodiesAntibody isotypingAntivenomCoral snakeHigh-throughput sequencingMicrurus nigrocinctusMurine immune responseToxinsTranscriptomicsVenom

Identifiers

PMID28149694
PMCPMC5267563
OpenAlexW2519726361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.